Background-The atheromodulating activity of B cells during the development of atherosclerosis is well documented, but the mechanisms by which these cells are regulated have not been investigated. Methods and Results-Here, we analyzed the contribution of Qa-1-restricted CD8 + regulatory T cells to the control of the T follicular helper-germinal center B-cell axis during atherogenesis. Genetic disruption of CD8 + regulatory T cell function in atherosclerosis-prone apolipoprotein E knockout mice resulted in overactivation of this axis in secondary lymphoid organs, led to the increased development of tertiary lymphoid organs in the aorta, and enhanced disease development. In contrast, restoring control of the T follicular helper-germinal center B-cell axis by blocking the ICOS-ICOSL pathway reduced the development of atherosclerosis and the formation of tertiary lymphoid organs. Moreover, analyses of human atherosclerotic aneurysmal arteries by flow cytometry, gene expression analysis, and immunofluorescence confirmed the presence of T follicular helper cells within tertiary lymphoid organs.
T he role of B cells in atherogenesis is currently being debated. T-independent innate-like B cells and the natural antibodies that they produce might be endowed with atheroprotective properties, 1,2 whereas T-dependent B cells have proatherogenic potential. 3, 4 A major feature of these T-dependent B cells is that the antibodies they produce result from heavychain class switching and affinity maturation. These events occur in germinal centers (GCs) within secondary lymphoid organs but can also occur in tertiary lymphoid organs (TLOs). TLOs are formed in tissues subjected to chronic inflammation 5 such as atherosclerotic arteries because B-cell lymphoid follicles are present in the adventitial layer of these arteries. [6] [7] [8] [9] [10] However, B-cell activation and differentiation into memory or plasma cells require help from T follicular helper (Tfh) cells. 11 This process is a critical checkpoint in the adaptive immune response because, when crossed, the production of potentially self-reactive affinity-matured specific antibodies can be triggered for the life span of the organism. Consequently, Tfh cells must be finely regulated to avoid the overactivation or differentiation of B cells and the development of autoimmune pathologies, a regulatory task that may be allotted to Qa-1-restricted CD8 + regulatory T cells (CD8+ Tregs).
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CD8
+ Tregs are known to be critical gatekeepers for the control of autoreactive CD4 + T cells. [12] [13] [14] [15] [16] Previously unsuspected cell targets of CD8 + Tregs are Tfh cells because of their high basal expression of the Qa-1 molecule, 14 which is the mouse ortholog of the HLA-E molecule. The Qa-1 molecule can establish 2 types of molecular interactions: One with T cell receptors (TCRs) on CD8 + Tregs and the other with NKG2A receptors on CD8 + T cells and natural killer cells. 17 To discriminate between the effects caused by NKG2A signaling and those resulting from TCR signaling, we used a transgenic mouse strain in which a point mutation was inserted into the Qa-1 molecule (D227K), thereby specifically abrogating its interaction with the TCR of CD8 + Tregs.
14 By crossing the D227K mice with atherosclerosis-prone apolipoprotein E-knockout (ApoE°) mice, we could study how the control of the Tfh-GC B-cell axis by CD8 + Tregs affects the development of atherosclerosis. In parallel, we could comprehensively characterize Tfh cells in human atherothrombotic aortas. These studies clearly identify Tfh cells as key regulators of the proatherogenic B-cell responses.
Methods
Human Tissues
Abdominal aortic aneurysm (AAA) tissues were obtained from patients undergoing surgery and enrolled in the RESAA (REflet Sanguin de l'evolutivité des Anevrysmes de l'aorte abdominale) protocol. All patients gave written informed consent, and the protocol was approved by the Comite Consultatif de Protection des Personnes dans la Recherche Biomédicale (Paris-Cochin, approval No. 2095). Only noninflammatory AAAs with documented atheroma were selected for our studies. Control aortas were sampled from dead organ donors with the authorization of the French Biomedicine Agency (PFS 09-007). These control aortic samples were nonaneurysmal (N-AA) and devoid of thrombi but could present early atheromatous lesions.
Mice
ApoE° mice were purchased from the Jackson Laboratory, and generation of the Qa-1° and D227K (Qa-1 D227K/D227K ) mice was described previously. 17, 18 The experimental protocol was approved by the Animal Ethics Committee of the Institut National de la Santé et de la Recherche Médicale and was therefore performed in accordance with the ethics standards detailed in the 1964 Declaration of Helsinki and its later amendments. Review and approval of the study were also obtained from the Comité d'Éthique Paris-Nord #121 (No. B 7518 03). The groups of mice used, the treatment to which they were subjected, and the biochemical analyses performed on their blood are described in the online-only Data Supplement.
Cell and Tissue Analyses
Atherosclerotic lesions were measured as previously described. 1 Human and mouse tissues were characterized by immunohistochemistry. Cell suspensions were analyzed by flow cytometry. Please refer to the online-only Data Supplement for the detailed methods.
Adoptive Cell Transfer
The protocols used to transfer CD4 + T cells and CD8+ Tregs are described in the online-only Data Supplement.
Gene Expression Analysis
Total RNA extracted from cells sorted from human aortas was analyzed by real-time polymerase chain reaction, as described in the online-only Data Supplement.
Statistical Analysis
Statistical analyses were performed with the JMP9 and Prism software programs. Differences between groups were considered to be statistically significant when P<0.05 using the appropriate tests. We used Student t tests or 2-way ANOVA tests followed by Tukey post hoc tests when values were normally distributed or nonparametric Mann-Whitney tests when values were not normally distributed or when the population size was too small (n<8), as specified in the figure legends. Aortic B-cell cluster incidence was analyzed by use of a log-rank test.
Results
Expansion of Tfh and GC B Cells During Atherosclerosis Development
We first asked whether the Tfh cell population is modulated during atherosclerosis development and therefore compared the spleen cells of young (6 weeks old; n=3) and aged (40 weeks old; n=4) ApoE° mice. In the ApoE° mice, aging did not modify the overall percentage of CD4 + T cells ( Figure 1A ). However, the proportion of activated memory (CD44 
CD8
+ T-cell population, in which CD8
+ Tregs are enriched, 15 was sharply reduced, resulting in a dramatic increase in the Tfh cell/CD8 + Treg ratio ( Figure 1A and 1B) . Concomitantly, the aged ApoE° mice displayed a reduced percentage of splenic B cells (B220 + ), whereas the percentage of GC B cells significantly increased ( Figure 1A and 1B). This observation was not reproduced in 40-week-old wild-type mice (data not shown), indicating that the effect is related to hypercholesterolemia and not to aging. Furthermore, the increased GC B-cell compartment was associated with increased immunoglobulin titers in the plasma of aged ApoE° mice ( Figure IA in the online-only Data Supplement).
These data suggest that atherogenesis in ApoE° mice is characterized by defective Tfh cell regulation by CD8 + Tregs and the mirrored expansion of GC B cells.
CD8 + Tregs Control Tfh Cells in ApoE° Mice
To control the Tfh-GC B-cell axis in ApoE° mice, 40-weekold ApoE° mice were injected with cell suspensions enriched in CD8 + Tregs (n=3; CD44 
Qa-1-Restricted CD8 + Tregs Control Atherosclerosis Development in ApoE° Mice
To assess whether the CD8 + Tregs act through a TCR/Qa-1 interaction, ApoE° mice were crossed with Qa-1° mice or D227K mice.
Fatty streak lesions had similar sizes in the 3 groups at 8 weeks of age (n=12 ApoE°, n=7 ApoE°-Qa-1°, n=16
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ApoE°-D227K; Figure IE in the online-only Data Supplement). However, the ApoE°-D227K mice (n=14 and n=9) developed significantly bigger plaques than did the ApoE° (n=13 and n=12) and ApoE°-Qa-1° (n=10 and n=10) mice at 15 and 35 weeks of age ( Figure 1E and Figure ID in the online-only Data Supplement). Additionally, the plaques of the 35-weekold ApoE°-D227K mice displayed more intense CD68, vascular cell adhesion molecule-1, and IgG staining than did the 2 other strains, whereas IgM staining was similar among the 3 groups ( Figure 1F and Figure ID in + effector T cells being no longer protected against natural killer lysis. Consequently, most of the following studies were pursued with ApoE°-D227K mice.
Impaired CD8 + Treg Function Leads to Tfh and GC B-Cell Expansion
The aforementioned results indicate that B-cell responses are exaggerated in ApoE°-D227K mice. In support of this finding, 35-week-old ApoE°-D227K mice (n=4) displayed a significantly increased proportion of splenic Tfh cells compared with age-matched ApoE° mice (n=5; Figure 2A Figure 2B ). The GL-7/IgD surface-to-area ratio was also significantly increased in the ApoE°-D227K mice ( Figure 2D ), indicating greater Ig class-switching activity in their splenic B-cell follicles compared with the age-matched ApoE° mice. This finding was corroborated by an increased plasma cell population in the spleen (but not lymph nodes) of aged ApoE°-D227K mice ( Figure IID in the online-only Data Supplement).
In contrast, the peritoneal B-1 cell populations were not affected by the D227K mutation ( Figure IIE in the online-only Data Supplement). Of note, CD4 + Th1 polarization was augmented in the ApoE°-D227K mice compared with the ApoE° mice ( Figure 2C ). Additionally, the 2 groups of mice had similar proportions of Th17 cells and CD25 
Defective Tfh Cell Regulation by CD8 + Tregs Accelerates Atherogenesis
The previous experiments collectively indicated that the con- Twenty weeks after the first injection, atherogenesis was accelerated in the ApoE° mice that received the CD4 + T cells from the ApoE°-D227K mice (ApoE°-D227K→ApoE°; n=10; Figure 3A ). The proportions of splenic CD4 + T cells, activated memory cells, and Tfh cells were also increased compared with the proportions in the ApoE°→ApoE° recipient mice (n=9; Figure 3B ). There were no differences between the 2 groups with respect to the frequencies of the splenic Th1, Th17, and Th2 populations ( Figure 3C ). Importantly, the percentage of splenic GC B cells increased in the ApoE°-D227K→ApoE° mice compared with the ApoE°→ApoE° mice ( Figure 3D) . Accordingly, the number of B cell follicles (IgD + ) and the number and density of GCs (IgD − GL-7 + ) were also increased, whereas the size of the B-cell follicles did not change ( Figure 3E ), indicating a specific effect on the GC reaction. In addition, the plaques of the ApoE°-D227K→ApoE° mice displayed a nonstable phenotype, with enhanced deposits of IgG (but not IgM), increased infiltration of CD68 + macrophages, and decreased α-smooth muscle actin content ( Figure 3F and Figure IIIB in the online-only Data Supplement).
Restoring Tfh Control in ApoE°-D227K Mice Reduces Atherosclerosis
To restore the control of the expanded Tfh cells observed in the ApoE°-D227K mice or to reduce, if possible, the limited by guest on February 9, 2015 http://circ.ahajournals.org/ Downloaded from February 10, 2015 contingent of Tfh cells in the ApoE° mice, mice from both genotypes were treated with an anti-ICOSL antibody (known to impair Tfh cell development) 19, 20 or an isotype control for 10 weeks (n=9-10 per group). Strikingly, the anti-ICOSL treatment normalized atherosclerosis development in the ApoE°-D227K mice (but not in ApoE° mice) to the level in the isotype control-treated ApoE° mice ( Figure 4A ). Additionally, the intraplaque IgG deposits were drastically reduced in the anti-ICOSL-treated ApoE°-D227K mice ( Figure 4B and Figure  IVA in the online-only Data Supplement). IgG was also decreased, although to a lower extent, in the treated ApoE° mice, in which there was also a decrease in the CD68 + macrophage intraplaque content ( Figure 4C and Figure These results show that the impact of the anti-ICOSL antibody treatment was maximal in the ApoE°-D227K mice, in which it significantly reduced the size of the Tfh cell compartment, limited the GC reaction, and drastically reduced lesion development.
Tfh Cells Regulate the Formation and Maintenance of Aortic TLOs
We found that CD23 was expressed by most of the CD19 + leukocytes in the aortas of the ApoE° and ApoE°-D227K mice revealed that the percentages of B and CD4 + T cells did not differ between the 2 mouse models. However, the proportions of activated memory and Tfh cells were significantly increased in the aortas of the ApoE°-D227K mice (n=8) compared with ApoE° mice (n=9; Figure 5A and 5B). The topographical distribution of B cells in the aortas was then analyzed in ApoE° and ApoE°-D227K mice on wholemount preparations of the adventitial layer labeled with a B220 B-cell-specific antibody. 10 B cells were clustered into TLO structures identified as B220 + B-cell follicles supplied with isolectin B4 + blood vessels and drained by Gp38 + lymphatic vessels ( Figure 5C ). Interestingly, the ApoE°-D227K mice (n=52) developed a greater number of adventitial B-cell clusters, which appeared earlier than in the ApoE° (n=49) and ApoE°-Qa-1° (n=27) mice ( Figure 5D ). Finally, anti-ICOSL antibody treatment reduced the number of B cell clusters in the adventitias of the ApoE° and ApoE°-D227K mice ( Figure 5E ).
This set of data strongly suggests that Tfh cells are involved in the formation or maintenance of adventitial TLOs.
TLOs in Human Atherosclerotic Aneurysmal Arteries
The observations made in our mouse model are relevant to human atherothrombosis because in most of the clinical samples of atherosclerotic AAAs that we collected, we detected mature TLOs, which can be coarsely identified by hematoxylin and eosin staining ( Figure 6A ). Additionally, CD20 + B-cell follicles surrounded by PNAd + high endothelial venules were observed ( Figure 6B ). The B-cell follicles were structurally similar to the ones described in secondary lymphoid organs, and most of them contained GCs, as characterized by the presence of Gp38
+ follicular dendritic cells ( Figure 6C ). The expression of homeostatic chemokines such as CXCL13 by follicular dendritic, Tfh, and B cells likely participates in the maintenance of the compartmentalized organization of these structures ( Figure 6B and 6C) . 21 Importantly, although A paired comparison of the leukocytes within the blood and adventitia of the same patient revealed a dramatic enrichment (5-fold) of B cells within the adventitia ( Figure 6D ). This finding indicated that B cells that infiltrate into atherothrombotic aneurysmal aortas are not a mere representation of systemic patrolling B cells but rather are B cells that are specifically attracted to or locally generated in the adventitia. Indeed, the phenotypes of the B cells in the 2 compartments were not the same, with an increase in memory B cells (IgD − CD38 − CD27 high ), GC B cells (IgD − CD38 + ), and plasma cells (IgD − CD38 high ), together with a decreased proportion of naïve B cells (IgD + CD38 − CD27 low ), within the adventitia compared with the paired blood sample (the decrease in CD27 brightness in the adventitia resulted from the digestion process; Figure 6D ). Absolute quantification of the cells within the adventitias of AAAs revealed an increase in CD45
+ cells compared with cells in the nonaneurysmal adventitia (N-AA) samples ( Figure 6E ). The adventitias of the AAAs (n=8) also showed a strong increase in the number of HLA-DR + CD19 + cells and in various adventitial B-cell subsets compared with the N-AA adventitias (n=13; Figure 6E ). Pre-GC B cells, GC cells, and plasma cells, which were virtually absent from the adventitias of the N-AAs, could also be detected in the adventitias of the aneurysms ( Figure 6E ).
The Adventitia of Aneurysmal Aortas Releases Immunoglobulins and Tfh-Related Cytokines
We next examined the release of immunoglobulins and cytokines from conditioned medium (CM) prepared from the adventitial layers of N-AAs (n=15) and AAAs (n=15) to document the functionality of the adventitial TLOs. All classes of immunoglobulins were increased in the CM from the AAAs compared with the N-AAs ( Figure 7A ). We found that cytokines known to participate in T-cell survival (interleukin [IL]-2, IL-7), T-cell effector function (interferon-γ, IL-17A, IL-4), inflammation (IL-1β, tumor necrosis factor-α), and B-cell function (IL-21, CD40L, IL-10) were increased in the CM from the AAAs compared with the control aortas ( Figure 7B ). Among the tested cytokines, IL-21 is particularly relevant to the immunobiology of TLOs because it is produced predominantly by Tfh cells and is essential for B-cell activation, B-cell expansion, and plasma cell generation. 22 Remarkably, we found significant positive correlations between the amount of IL-21 and the amounts of IgG1, IgG4, and total immunoglobulins within the CM. Strikingly, the concentration of IL-21 in the CM from the AAAs positively correlated with the AAA diameter ( Figure 7C) .
Collectively, these data demonstrate that Tfh cells are present in the adventitias of human AAAs, where they may participate in the progression of the disease by promoting the local maturation of seemingly pathogenic B cells. Therefore, we next assessed whether we could directly detect and isolate Tfh cells from human aortas by flow cytometry. . Notably, genome-wide association studies revealed that MAF and CXCL13 gene polymorphisms are associated with cardiovascular diseases/risk factors. 23 In addition, the extensive transcriptomic study performed by Lenk et al 24 
revealed that most of the genes (except BCL6) involved in
Tfh cell biology are upregulated in noninflammatory human AAAs compared with control aortas. Therefore, the adventitias of human AAAs are infiltrated by Tfh cells that display some canonical features of secondary lymphoid organ Tfh cells, in particular those involved in the help that Tfh cells provide to B cells. Accordingly, the 
Discussion
Intensive investigations in the fields of atherosclerosis and vascular biology have identified the regulatory mechanisms that govern the immune response involved in plaque growth. [25] [26] [27] [28] Initial studies 1, 29, 30 indicated the atheroprotective potential of the B-cell compartment that relies on B1a cells and germ-line-encoded immunoglobulins. In contrast, recent studies have identified T-dependent B cells (B2 cells) as potent proatherogenic mediators in the ApoE° and low-density lipoprotein receptor-knockout mouse models.
3,4 B-cell activation, proliferation, and function are orchestrated by Tfh cells, 11 the regulation of which is crucial to avoid the development of self-reactive humoral responses. 31 This regulation can be performed by Qa-1-restricted CD8 + Tregs.
14 Our data now demonstrate that through their control of Tfh cell function, CD8 + Tregs are potent modulators of atherogenesis. We first found a concomitant expansion of Tfh and GC B cells in parallel with a loss of CD8 + Tregs during atherosclerosis development in ApoE° mice. The further impaired function of CD8 + Tregs triggered in the ApoE°-D227K mice led to overactivation of the Tfh-GC B-cell axis. Remarkably, this event favored the development of atherosclerosis. Restoring control of the Tfh-GC B cell axis by blocking the ICOS-ICOSL interaction reduced lesion development in the ApoE°-D227K mice. In addition, for the first time, we describe the involvement of Tfh cells in the formation and maintenance of adventitial ectopic GCs in atherothrombotic arteries. Finally, we show that these observations are fully relevant to human disease because we could comprehensively characterize Tfh cells in human atherothrombotic aortas.
TLOs cannot be considered passive bystander markers of tissue inflammation because their formation marks a turning point in chronic inflammatory processes. In alloimmune responses, TLOs promote the antibody-mediated destruction of grafts. [32] [33] [34] In autoimmune diseases, TLOs are clearly detrimental, promoting autoantibody production and activating cellular effectors, both of which result in organ damage. 34, 35 In the present study, we report that atherosclerosis development in ApoE° mice is characterized by an expansion of Tfh cells within aortic adventitial TLOs and that TLO development and maintenance are dependent on the Tfh cell compartment. Although we could not correlate TLO formation with plaque development (our whole-mount technique requires the separation of the adventitia from the rest of the vessel), it is important to note that Gräbner et al 9 have demonstrated that TLO size is correlated with plaque size and that TLOs always develop in atherosclerotic arterial segments in ApoE° mice.
We also fully characterized the presence and functional phenotype of Tfh cells in the adventitial TLOs of human AAA. The adventitial tissue of AAAs released immunoglobulins, thereby indicating that adventitial TLOs are functional B-cell structures. Strikingly, in the CM of AAA adventitia, the concentration of IL-21, a prototypic Tfh cell cytokine, was positively correlated with the diameter of the aneurysm, strongly suggesting that the Tfh-dependent B-cell response is directly linked to the progression of the disease. In addition to IL-21, the adventitial layer of AAAs is an inflamed microenvironment where high concentrations of many cytokines are detected. We believe that the topological organization of the arterial wall places the adventitia in a position where it concentrates most of the soluble/particulate mediators that percolate radially from the lesions, 36 thereby resulting in a high inflammatory profile that promotes lymphoid neogenesis on this layer.
Conclusions
We found that the Tfh-GC B-cell axis is centrally involved in the development of mouse and human atherosclerosis. We show that this axis is under the control of CD8 + Tregs and provide the first line of evidence indicating that, beyond their role in secondary lymphoid organs, Tfh cells are also key players in the GC reaction that develops in TLOs ( Figure VIII in the online-only Data Supplement). This study therefore paves the way for innovative therapeutic strategies targeting this axis.
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CLINICAL PERSPECTIVE
B cells can modulate the development of atherosclerotic plaques. Their maturation into antibody-secreting cells is determined by T follicular helper cells. Here, we show that newly identified CD8 + T regulatory cells control the activity of T follicular helper and B cells and consequently atherogenesis. We have identified the adventitial layer as a critical location for atherosclerosis-associated immune activity. Indeed, we show that lymphoid aggregates develop around human atherothrombotic arteries, particularly aortas affected by atherothrombotic aneurysms, are enriched in T follicular helper and B cells, and release immune effectors. Using mouse models, we demonstrate that disrupting the T follicular helper-B-cell axis with an anti-ICOSL antibody is a strategy that suppresses the formation of lymphoid aggregates around diseased arteries. Importantly, the use of this strategy also limits lesion development. Given the specificity of action of anti-ICOSL antibodies, they are good candidates for human translational trials. Indeed, they are currently being tested in lupus patients (http://www. ClinicalTrials.gov; NCT00774943). This approach could be considered to stop aneurysm progression.
SUPPLEMENTAL MATERIAL Supplemental Methods
Human tissues
AAA tissues were obtained from patients undergoing surgery and enrolled in the RESAA protocol (REflet Sanguin de l'evolutivité des Anevrysmes de l'aorte abdominale). All patients gave informed written consent, and the protocol was approved by the Comite Consultatif de Protection des Personnes dans la Recherche Biomédicale (CCPRB, Paris-Cochin, approval no. 2095). Control aortas were sampled from dead organ donors with the authorization of the French Biomedicine Agency (PFS 09-007). These control aortic samples were non-aneurysmal (N-AA), devoid of thrombus but could present atheromatous lesions.
Mice
ApoE° mice were purchased from the Jackson Laboratory. The generation of the Qa1° and D227K (Qa1 D227K/D227K ) mice was described previously 1, 2 . All mice were maintained on a C57BL/6J background and had a Qa-1 b haplotype. The Qa1° and D227K mice were crossed with the ApoE° mice. The heterozygous offspring were then intercrossed to generate homozygous ApoE°-Qa1° and ApoE°-D227K mice. All animals were maintained on a regular chow diet and handled in accordance with European Union directives (86/609/EEC) on the care and use of laboratory animals in our facility. For each experiment, the mice were sacrificed by exsanguination under anesthesia (intraperitoneal injection of 100 mg/kg ketamine-HCL and 20 mg/kg xylazine). The experimental protocol was approved by the Animal Ethics Committee of the Institut National de la Santé et de la Recherche Médicale and was therefore performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Review and approval of the study was also obtained from the Comité d'Éthique Paris-Nord #121 (no. B 7518 03).
Analysis of the atherosclerotic lesion extent
The extent of atherosclerotic lesions was measured in oil red O-stained cryosections of mouse aortic roots, as previously described 3 . Images were captured on a Zeiss Axiovert 200 M inverted microscope. A program developed in Quips language (Leica) allowed for the quantification of the surface area of the lesion and the total surface area of the aorta.
Phenotypic analysis of the atherosclerotic plaques
Transverse cryosections (10 µm thick) of mouse aortic roots were fixed in 4% paraformaldehyde (PFA). The slides were pre-incubated in blocking solution [5% bovine serum albumin (BSA), 0.1% Fish Gelatin and 100 mM Glycine] for 30 minutes. The samples were then incubated overnight at 4°C with the following fluorochrome-coupled primary antibodies: rat anti-mouse IgM (polyclonal, DyLight649, Jackson ImmunoResearch) and rat anti-mouse IgG (polyclonal, rhodamine, Jackson ImmunoResearch) or with the following purified primary antibodies: rat anti-mouse CD68 (clone FA-11, Serotec), rabbit anti-mouse α-SMA (polyclonal, Abcam), and goat anti-mouse VCAM-1 (polyclonal, R&D Systems). After several washes, the cryosections that were stained with the purified primary antibodies were incubated with the appropriate antibody (anti-rabbit TRITC; anti-rat DyLight649, Jackson ImmunoResearch) for 1 hour at room temperature (RT), and the slides were cover-mounted using Prolong Gold Antifade Reagent® (Invitrogen) for microscopy. To compare the plaque phenotypes between the different groups, we analyzed the ratio of the positively stained area (for each primary antibody) to the total lesion area.
Flow cytometry analysis
For mouse tissue analysis, the adventitial layer of the aorta, the inguinal and brachial lymph nodes, and the spleen were harvested for flow cytometry. The spleen and lymph nodes were disaggregated on a 70 µm filter to obtain a single cell suspension. Only results concerning the spleen are provided since those obtained with lymph node cells were redundant. The aorta was cut into small pieces and digested for 1 hour in 0.6 mg/mL Collagenase P (Roche), 2.4 mg/mL Dispase (Roche) and 0.3 mg/mL (Roche) in DMEM media at 37°C under constant shaking, as previously described 4 . A cell suspension from the peritoneum was obtained by peritoneal lavage with 5 mL of ice-cold PBS. After several washes with PBS, the cells were incubated with an anti-CD16/32 (Fc block, BD Biosciences) for 15 minutes at RT. The cells were washed and incubated for 30 minutes at 4°C with the antibodies described in Supplemental Table II . After an extensive wash, the cells were analyzed by flow cytometry. For the quantification of intracellular cytokines, the cells were incubated in 200 ng/mL phorbol-myristate-acetate (PMA, Sigma) and 500 ng/mL ionomycin (Sigma) in 24-well plates (10 6 cells/well) for 4 hours at 37°C, and Golgi Stop (1/1500, BD Biosciences) was added for the last 2 hours of the incubation. After several washes, the cells were stained for surface molecules, followed by fixation, permeabilization, and intracellular staining with the mouse Th1/Th2/Th17 phenotyping kit (BD Biosciences) according to the manufacturer's instructions. For the analysis of CD4 + Tregs and for KI-67 and Bcl6 staining, the mouse regulatory T cell staining kit (eBioscience) was used according to the manufacturer's instructions. For human tissue analysis, adventitial layer samples from the AAA and N-AA subjects were weighed, cut into small pieces (<1 mm) and digested using a previously described protocol 4 . After a wash step, the cells were stained with the antibodies described in Supplemental Table II . Flow cytometry analysis was performed using an LSR II flow cytometer (BD Biosciences), and fluorescence activated cell sorting was performed with an ARIA III cell sorter (BD Biosciences). Data were analyzed with DIVA (BD Biosciences) and FlowJo (TreeStar) software.
Analysis of spleen GCs
Cryosections (10 µm thick) of mouse spleens were fixed in 4% PFA. The slides were incubated with avidin/biotin blocking solution (Dako) for 20 minutes and Mouse-on-Mouse Ig blocking solution (Vector) for 1 hour. The slides were then incubated with primary antibody (biotinylated mouse antimouse IgD, clone 217-170, BD Biosciences; rat anti-mouse GL7, clone Gl7, eBioscience) for 1 hour at 37°C. After several washes, the samples were incubated with the appropriate secondary antibody (TRITC-conjugated goatrat IgG, polyclonal, Jackson ImmunoResearch; Alexa Fluor 647 streptavidin A647, Life Technologies) for 45 minutes at RT, and the slides were covermounted using Prolong Gold Antifade Reagent® (Invitrogen) for microscopy. For quantitative analysis, the GC density was calculated as follows: GL7-positive area*100/IgD-positive area.
Whole mount immunofluorescence staining of the mouse aortic adventitia
The mouse aortic adventitia was separated from the medial tube using binoculars and then processed as described previously 5 . Briefly, the adventitia was fixed in 4% PFA overnight and permeabilized with 0.6% Triton for 2 hours at RT. Purified rat anti-mouse B220 (RA3-6B2, BD Biosciences), isolectin B4 (Vector Laboratories) and primary hamster anti-mouse Gp38 (polyclonal, Angiobio) were used to stain the adventitia. After several washes, the adventitia was incubated with the appropriate secondary antibody (polyclonal rabbit anti-hamster DyLight488; goat anti-rat DyLight649, Jackson Immunoresearch) for 1 hour at RT, and the slides were cover-mounted using Prolong Gold Antifade Reagent® (Invitrogen) for microscopy.
Adoptive transfer of CD4 + T cells
Spleens were harvested from 8-week-old ApoE° or ApoE°-D227K° (n=10/group) male mice and meshed through a 70 µm cell strainer (BD Biosciences). The resultant cell suspensions were processed for CD4 + T cell purification using the CD4 T Lymphocyte Enrichment Set (BD Biosciences) according to the instructions of the manufacturer. The CD4 + T cell purity and phenotype were analyzed by flow cytometry. The CD4 + T cells were 85% pure in each preparation and displayed the same activation phenotype (CD62L, CD44, CD25) in each group. Male ApoE° recipient mice (n=9-10/group, 15 weeks old) received 2 injections of the purified CD4 + T cells (10 7 cells/mouse/injection), 10 weeks apart. The mice were sacrificed at 35 weeks of age.
Adoptive transfer of CD8 + Tregs
Under sterile conditions, spleens and lymph nodes (inguinal, axillary, brachial) were harvested from ApoE° mice (females, 8 weeks old, n=10) and meshed through a 70 µm cell strainer to obtain cell suspensions in PBS. The CD8 + T cells were stained to perform a FACS-based purification to obtain fractions enriched in memory (CD44 
Anti-ICOS ligand antibody treatment
Fifteen-week-old ApoE° and ApoE°-D227K mice (n=10 mice/group) received a weekly i.p. injection of 100 µg anti-ICOSL antibody (clone HK5.3, rat IgG2a anti-mouse) or isotype control (BioXcell). After 10 weeks of treatment, the mice were euthanized, blood samples were collected by puncture to obtain plasma, their hearts were frozen for analysis of aortic root lesions, their adventitias were dissected for TLO analysis, and their spleens were used for flow cytometry analysis and cryosections.
Immunohistochemistry on human samples
Human AAA and N-AA tissues were fixed in 4% PFA, embedded in paraffin and sectioned at 6 µm. The sections were deparaffinized in toluene, hydrated in ethanol and incubated in retrieval reagent (R&D Systems) for 20 minutes. After blocking in 5% BSA, the slides were incubated with purified primary antibody (mouse anti-human CD20, clone L-26; rabbit anti-human CD3, polyclonal, Dako; rat anti-human PNAd, MECA-79, BD Biosciences; rat antihuman Gp38, clone NZ-1, Angiobio; goat anti-human CXCL13, polyclonal, R&D Systems; rabbit anti-human CD21, clone EP3093, Abcam) or fluorochrome-coupled primary antibody (rat anti-human AICDA Alexa Fluor 488, clone 911, Abcam) overnight at 4°C. After several washes with PBS, the slides that were stained with the purified primary antibodies were incubated with the appropriate secondary antibody (polyclonal goat anti-rabbit DyLight649; goat anti-mouse rhodamine; goat anti-rat rhodamine; donkey anti-mouse rhodamine, Jackson Immunoresearch) at RT for 30 minutes and then cover-mounted using Prolong Gold Antifade Reagent® (Invitrogen) for microscopy. The resulting fluorescence was detected with a Zeiss Axiovert 200 M microscope equipped with an AxioCam MRm version 3 camera, an ApoTome ® system and AxioVision ® image capture software.
Gene expression analysis
Total RNAs were extracted from cells sorted from human aortas using the TRIzol® reagent, and mRNA reverse transcription was performed using iScript reverse transcriptase (BioRad). Real time quantitative PCR (RT-qPCR) was performed on a CFX 100 thermocycler (BioRad) using the primers listed Supplemental Table I . One nanogram of cDNA from each sample was mixed with forward and reverse primers (250 nM) and SYBR Green master mix (Qiagen) in a total reaction volume of 22 µL. The amplification program was as follows: 1 cycle at 50°C for 2 minutes; 1 cycle at 95°C for 15 minutes; and 50 cycles at 95°C for 40 sec and 60°C for 1 minute. The data were analyzed using the 2 -∆∆Ct Pfaffl formula 6 , and the Ct values of the genes of interest were normalized to the Ct values of β-actin (primers sequences are listed in Supplemental Table III) . Clustering classification was performed using JMP9.
Biochemical analysis of mouse blood samples
To determine the total blood cell count in the mouse blood samples, fresh EDTA-anticoagulated blood samples were harvested from sacrificed mice and analyzed on a Vet ABC analyzer. The plasma was then separated by centrifugation at 2000 g for 15 minutes, and the plasma cholesterol and highdensity lipoprotein (HDL) concentrations were measured using Infinity® Cholesterol-Liquid reagents and an Olympus AU-400 multiparametric analyzer. The data for the blood cell counts and lipid concentrations are displayed in Supplemental Table I .
Statistical analysis
Statistical analyses were performed using the JMP9 and Prism software programs. We used Student's t-tests or two-way ANOVA tests followed by Tukey's post-hoc tests when values were normally distributed, or nonparametric Mann-Whitney tests when it was not the case or when population size was too small (n<8), as specified in the figure legends. + Treg cells. Consequently, the Tfh cell-dependent GC-B cell response is exaggerated in SLOs and in aortic TLOs, which leads to an accentuated atherosclerotis. The injection of anti-ICOSL antibody in ApoE°-D227K mice restored the control of the Tfh-GC B cell axis, and reduced the development of atherosclerosis.
